Immunosuppression
157
22
25
77
Key Insights
Highlights
Success Rate
88% trial completion (above average)
Published Results
22 trials with published results (14%)
Research Maturity
77 completed trials (49% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
7.0%
11 terminated out of 157 trials
87.5%
+1.0% vs benchmark
26%
41 trials in Phase 3/4
29%
22 of 77 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 77 completed trials
Clinical Trials (157)
Oral Bacteria and Immune System Problems Involved in Gum Disease (Periodontitis)
Immunomodulation to Optimize Vascularized Composite Allograft Integration for Limb Loss Therapy
Safety and Immunogenicity of Recombinant Zoster Vaccine for Transplant Recipients
Combined Immunosuppression for Pediatric Crohn's Disease
Evaluation of the Benefits of Administering Immunosuppressive Drugs as Single Daily Doses Over the First Year After Liver Transplantation (EASY)
Adaptation of Lung Transplant Recipients at Extreme Altitude
HLA-Identical Sibling Renal Transplant Tolerance
Effect of Cognitive Therapy on Immunosuppressive Treatment Compliance and Motivation
(TNX-1500) in Kidney Transplant Recipients
Torque Teno Virus: A Biomarker of Immunosuppression
Safety and Efficacy of an Inactivated and Non Adjuvanted Vaccine Against Influenza A in Renal Transplant Recipients
Vascularized Composite Bladder Allograft Transplantation
Fibroscan to Guide Post Transplant Immunosuppression Minimization
Pathological Myeloid Activation After Sepsis and Trauma
Analysis of the Specificity and Persistence of Nasal Immune Responses to Respiratory Viral Antigens in Immunocompromised and Healthy Cohorts
Islet Cell Transplantation in Patients With Type I Diabetes With Previous Kidney Transplantation
Additional Recombinant COVID-19 Humoral and Cell-Mediated Immunogenicity in Immunosuppressed Populations
Effectiveness and Cost-effectiveness of a Pre-emptive Genotyping Strategy in Patients Receiving Tacrolimus
Evaluation of PCV21 Vaccination Among PPSV23-experienced, Immunocompromised Elderly Veterans
ImmunoCARE: Rapid, Accurate COVID Testing to Reduce Hospitalization of Immunocompromised Individuals